Cargando…
Targeting the Vulnerabilities of Oncogene Activation
Autores principales: | Huang, Christina, Arbiser, Jack L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340594/ https://www.ncbi.nlm.nih.gov/pubmed/37444469 http://dx.doi.org/10.3390/cancers15133359 |
Ejemplares similares
-
Targeting of non-oncogene addiction
por: Igea, Ana, et al.
Publicado: (2015) -
Targeting DUBs to degrade oncogenic proteins
por: Cremer, Anjali, et al.
Publicado: (2020) -
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
por: Avtanski, Dimiter B., et al.
Publicado: (2015) -
MAVS is a double-edged sword
por: Huang, Christina, et al.
Publicado: (2023) -
Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia
por: Wang, Zhengqi, et al.
Publicado: (2021)